Incidence and Characteristics of Delayed Injection Site Reaction to the mRNA-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine (Moderna) in a Cohort of Hospital Employees

BACKGROUND: mRNA SARS-CoV-2 vaccines are administered to 2 million individuals per day in the United States under US Food and Drug Administration emergency use authorization. METHODS: Observational cohort study of hospital employees who received their first SARS-CoV-2 mRNA vaccination between 14 Dec...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobson, Mark A, Zakaria, Adam, Maung, Zaw, Hart, Colin, McCalmont, Timothy H, Fassett, Marlys, Amerson, Erin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244618/
https://www.ncbi.nlm.nih.gov/pubmed/34086881
http://dx.doi.org/10.1093/cid/ciab518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244618/
https://www.ncbi.nlm.nih.gov/pubmed/34086881
http://dx.doi.org/10.1093/cid/ciab518

Ejemplares similares